The Use of -omic Technologies for Biomarker Development
Michael Pfaffl, Principal Investigator, Technical University of Munich, speaking at Genomics Research Asia 2012
Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome
Dr Steven Sheridan, Harvard Medical School, speaking at Stem Cells 2012
Kinase Centric Chemical Proteomics Provides Novel Insights into Individual Cancer Biology
Bernhard Kuster, Technical University Munich, speaking at Systems Biology Europe 2012
An Integrated System Using Peptide Arrays to Assess Kinase and Nuclear Receptor Activities in Clinical Samples for Biomarker Development
Bertrand Jordan, Aix-Marseille University, speaking at Microarray World Congress 2012
Chemiluminescence-Based Biosensors for Point-of-Care Multiplex Sensing as a Companion Diagnostics in Personalized Medicine
Professor Aldo Roda, University of Bologna, speaking at Advances in Biodetection and Biosensors 2012.
Signalling Molecules as Proteomic Biomarkers in Brain Tumours
Radu Albulescu talking on behalf of Cristiana Tanase MD, PhD, Victor Babes University of Medicine and Pharmacy, Timisoara, speaking at Molecular Diagnostics Europe 2012.
Single Copy qPCR-Based Detection of BRAF and KRAS Mutations
Vladimir Makarov, Swift Biosciences Inc, speaking at Genomics Research 2012.
Understanding Cell Transitions at Single-Cell Level
Dr Anders Ståhlberg, University of Gothenburg in Sweden, speaking at Single Cell Analysis Europe 2012.
Challenges of Analyzing Single Cell Gene Expression Data
Dr Kenneth Livak, Fluidigm, speaking at Single Cell Analysis Europe 2012.